0
Articles   |    
Acrometastases. A study of twenty-nine patients with osseous involvement of the hands and feet

The Journal of Bone & Joint Surgery.  1986; 68:743-746 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case
text A A A

Abstract

We studied the records of twenty-nine patients with forty-one metastatic lesions of the hand or foot. In five patients the lesions mimicked a benign condition, and inappropriate treatment was given. In eleven patients the acrometastases were the first indication of malignant disease, and four other patients had no known primary malignant lesion. Amputation of a phalanx, digit, or ray is recommended for most solitary phalangeal, metacarpal, or metatarsal lesions when the expected period of survival of the patient exceeds a few months.

Figures in this Article
    This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

    Topics

    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.
    The New England journal of medicine: Issue date- 2012 Jan 26
    Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
    The New England journal of medicine: Issue date- 2012 Jan 26
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    12/22/2011
    ME - Central Maine Medical Center
    12/22/2011
    VA - Charleston Area Medical Center
    12/22/2011
    Maine - Central Maine Medical Center